Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
10.80
+0.25 (2.37%)
May 8, 2026, 1:46 PM CST
TPEX:4186 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 140.74 | 106.32 | 182.14 | 158.56 | 159.7 |
Cash & Short-Term Investments | 140.74 | 106.32 | 182.14 | 158.56 | 159.7 |
Cash Growth | 32.37% | -41.62% | 14.87% | -0.71% | -32.59% |
Accounts Receivable | 98.26 | 97.56 | 51.84 | 62.43 | 67.29 |
Other Receivables | - | - | - | 0.25 | 0.13 |
Receivables | 98.26 | 97.56 | 51.84 | 62.68 | 67.43 |
Inventory | 21.28 | 19.16 | 21.17 | 23.42 | 24.11 |
Prepaid Expenses | 5.36 | - | 3 | - | - |
Other Current Assets | 1.13 | 5.4 | 1.16 | 15.48 | 16.42 |
Total Current Assets | 266.76 | 228.45 | 259.3 | 260.13 | 267.66 |
Property, Plant & Equipment | 251.46 | 234.03 | 246.27 | 255.02 | 256.79 |
Long-Term Investments | 88.21 | 78.23 | 93.9 | 72.94 | 67.75 |
Other Intangible Assets | 0.17 | 0.2 | 0.22 | 3.53 | 10.14 |
Long-Term Deferred Tax Assets | 10.75 | 9.88 | 9.81 | 8.82 | 8.73 |
Other Long-Term Assets | 129.39 | 125.65 | 139.08 | 106.34 | 102.67 |
Total Assets | 746.74 | 676.42 | 748.57 | 706.77 | 713.74 |
Accounts Payable | 13.52 | 8.48 | 16.65 | 14.55 | 11.55 |
Accrued Expenses | - | 31.94 | - | - | - |
Short-Term Debt | 180 | 140 | 180 | 130.95 | 107.86 |
Current Portion of Long-Term Debt | 15.55 | 24.54 | 36.52 | 35.71 | 20.92 |
Current Portion of Leases | 2.89 | 4.38 | 3.83 | 4.65 | 4.4 |
Current Unearned Revenue | 25.92 | 26.86 | 26.77 | 26.06 | 60.98 |
Other Current Liabilities | 34.35 | 2.69 | 53.05 | 31.15 | 39.36 |
Total Current Liabilities | 272.23 | 238.88 | 316.82 | 243.07 | 245.08 |
Long-Term Debt | 62.38 | 58.65 | 83.18 | 103.27 | 108.08 |
Long-Term Leases | 3.31 | 2.08 | 3.71 | 5.12 | 7.7 |
Long-Term Unearned Revenue | 121.86 | 118.54 | 109.08 | 109.07 | 109.63 |
Pension & Post-Retirement Benefits | - | - | - | - | 0.79 |
Long-Term Deferred Tax Liabilities | 0.99 | 0.85 | 0.97 | 0.71 | - |
Other Long-Term Liabilities | 0.88 | 0.98 | 0.89 | 0.89 | 1.01 |
Total Liabilities | 461.64 | 419.98 | 514.65 | 462.13 | 472.29 |
Common Stock | 900 | 900 | 900 | 900 | 900 |
Additional Paid-In Capital | - | - | - | - | 0.05 |
Retained Earnings | -613.85 | -642.51 | -665.72 | -654.95 | -658.6 |
Comprehensive Income & Other | -1.06 | -1.05 | -0.36 | -0.4 | - |
Shareholders' Equity | 285.1 | 256.44 | 233.92 | 244.64 | 241.45 |
Total Liabilities & Equity | 746.74 | 676.42 | 748.57 | 706.77 | 713.74 |
Total Debt | 264.12 | 229.64 | 307.24 | 279.7 | 248.97 |
Net Cash (Debt) | -123.38 | -123.32 | -125.11 | -121.15 | -89.27 |
Net Cash Per Share | -1.36 | -1.37 | -1.39 | -1.35 | -0.99 |
Filing Date Shares Outstanding | 90.95 | 90 | 90 | 90 | 90 |
Total Common Shares Outstanding | 90.95 | 90 | 90 | 90 | 90 |
Working Capital | -5.47 | -10.44 | -57.52 | 17.07 | 22.58 |
Book Value Per Share | 3.13 | 2.85 | 2.60 | 2.72 | 2.68 |
Tangible Book Value | 284.92 | 256.25 | 233.7 | 241.11 | 231.31 |
Tangible Book Value Per Share | 3.13 | 2.85 | 2.60 | 2.68 | 2.57 |
Land | - | 127.13 | 127.13 | 127.13 | 118.51 |
Buildings | - | 81.12 | 81.12 | 81.12 | 77.61 |
Machinery | - | 228.15 | 226.64 | 219.34 | 217.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.